Alerus Bulls Eye Record Profitability as Shorts Retreat
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
ALRS heads into its October 29 earnings report with short sellers backing away and options traders leaning decidedly bullish.
The clearest positioning signal is in the options market. The put/call ratio has dropped to 0.021, more than one standard deviation below its 20-day average of 0.068. That is close to the lowest reading of the past year, against a 52-week low of 0.005. Calls are dominating the options flow by a wide margin, suggesting investors are tilting toward upside into the print rather than hedging against disappointment. Short interest reinforces that picture. At 3.7% of the free float, it has fallen 24% over the past month and is down a further 5% on the week. Borrow conditions are loose, with availability at 1,396%, meaning roughly 14 shares are available to borrow for every one currently shorted. Cost to borrow is 0.42%, well below any level that would signal stress in the lending market. Positioning, in short, looks confident rather than cautious.
The analyst community has been incrementally more constructive in recent months. Piper Sandler upgraded ALRS to Overweight in early October, raising its target to $38. The consensus sits at a hold-equivalent rating with a mean price target of $35.20, implying about 9% above the current price of $32.27. The stock has gained nearly 3% on the week. Bulls point to net interest margin expansion of 8 basis points to 3.77%, a 24-basis-point drop in funding costs, and spread income of $44.9 million as evidence that earnings power is stronger than the market has priced. The bear case centres on loan contraction: loans declined 1.3% annualised last quarter and core fee income slipped 1% sequentially to $30.9 million, suggesting revenue breadth remains thin even as the headline metrics improved. The valuation sits at 11.3x trailing earnings and 1.25x book, modest multiples that give bulls a floor argument but leave limited room for execution misses.
FDIC call report data, published by the Federal Deposit Insurance Corporation, provides colour on the bank's underlying performance. The ORTEX Alt Data layer has not yet accumulated enough history to test whether this dataset leads ALRS's reported figures. However, the facts on record are notable: net income for Q2 2026 was the largest second-quarter result in the series since tracking began in 2024, at $22.9 million, and return on equity for the quarter reached 16.35%, also a record for any Q2 in the dataset. The dataset covers the period through June 30, 2026, so the current quarter's figures are not yet available.
Goldman Sachs Asset Management added a meaningful position in recent months, reporting ownership of 432,647 shares as of October 1, with a net addition of 386,798 shares over the prior period. That is one of the more active institutional moves in the register. BlackRock also added modestly. On the insider side, director Jeffrey Bolton made two open-market purchases in May and September at prices between $28.72 and $32.45, small in dollar terms but discretionary and executed at progressively higher prices. Net insider activity over 90 days is barely positive, so the signal is directional rather than emphatic.
The print will test whether the NIM expansion and profitability records visible in the June quarter data have held into Q3, and whether loan growth has stabilised enough to convince a broadly bullish market that Alerus has earned its ground.
Stocks in this article
See the live data behind this article on ORTEX.
Open ALRS on ORTEX →How this article was generated
- Generated
- 29 Oct 2026, 04:24
- Data as of
- 29 Oct 2026, 04:05
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.